130 related articles for article (PubMed ID: 6584501)
1. Effects of prostaglandin E on the proliferation and differentiation of leukemic progenitor cells in acute nonlymphocytic leukemia.
Ozawa K; Miura Y; Suda T; Motoyoshi K; Takaku F
Int J Cell Cloning; 1983 Dec; 1(6):440-50. PubMed ID: 6584501
[TBL] [Abstract][Full Text] [Related]
2. Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders.
Taetle R; Guittard JP; Mendelsohn JM
Exp Hematol; 1980 Nov; 8(10):1190-1201. PubMed ID: 6971757
[TBL] [Abstract][Full Text] [Related]
3. Modulation of normal and abnormal myeloid progenitor proliferation by cyclic nucleotides and PGE1.
Taetle R; Mendelsohn J
Blood Cells; 1980; 6(4):701-18. PubMed ID: 6258672
[TBL] [Abstract][Full Text] [Related]
4. In vitro differentiation of leukemic progenitor cells in various types of acute nonlymphocytic leukemia.
Ozawa K; Miura Y; Suda T; Motoyoshi K; Takaku F
Cancer Res; 1983 May; 43(5):2334-8. PubMed ID: 6187449
[TBL] [Abstract][Full Text] [Related]
5. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Pelus LM; Broxmeyer HE; Clarkson BD; Moore MA
Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324
[TBL] [Abstract][Full Text] [Related]
6. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
7. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
9. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
Karp JE; Burke PJ
Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
[TBL] [Abstract][Full Text] [Related]
10. Influence of fluoxymesterone on in vitro erythropoiesis affected by leukemic cells.
Bai GZ; Hara H; Nagai K
Exp Hematol; 1984 Mar; 12(3):171-6. PubMed ID: 6584313
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of human leukemic cells in vitro by L-ascorbic acid.
Park CH; Amare M; Savin MA; Hoogstraten B
Cancer Res; 1980 Apr; 40(4):1062-5. PubMed ID: 6928398
[TBL] [Abstract][Full Text] [Related]
12. Comparative influences of phytohemagglutinin-stimulated leukocyte conditioned medium, hemin, prostaglandin E, and low oxygen tension on colony formation by erythroid progenitor cells in normal human bone marrow.
Lu L; Broxmeyer HE
Exp Hematol; 1985 Nov; 13(10):989-93. PubMed ID: 4054250
[TBL] [Abstract][Full Text] [Related]
13. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
Somekh E; Douer D; Shaked N; Rubinstein E
J Pharmacol Exp Ther; 1989 Jan; 248(1):415-8. PubMed ID: 2913285
[TBL] [Abstract][Full Text] [Related]
15. Effects of 12-O-tetradecanoylphorbol-13-acetate on the proliferation and differentiation of normal and leukemic myeloid progenitor cells.
Ozawa K; Miura Y; Hashimoto Y; Kimura Y; Urabe A; Takaku F
Cancer Res; 1983 May; 43(5):2306-10. PubMed ID: 6831455
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic evaluation of chronic myeloid leukemia.
Moore MA; Mertelsmann R; Pelus LM
Blood Cells; 1981; 7(2):217-36. PubMed ID: 6945881
[TBL] [Abstract][Full Text] [Related]
17. Normal responsiveness of granulocyte macrophage committed stem cells from patients with chronic myeloid leukemia to proliferation inhibition by prostaglandin E 1.
Rao SG; Nadkarni KS; Joshi K; Kothari V; Advani SH
Indian J Exp Biol; 1984 Jun; 22(6):340-2. PubMed ID: 6595217
[No Abstract] [Full Text] [Related]
18. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil.
Reiner P; Mardiak J; Reinerová M; Ujházy V
Neoplasma; 1981; 28(5):533-9. PubMed ID: 6947140
[TBL] [Abstract][Full Text] [Related]
19. Responsiveness to prostaglandin E1 of different subtypes of normal and pathological committed granulomonopoietic precursors.
Aglietta M; Piacibello W; Gavosto F
Acta Haematol; 1983; 69(6):376-81. PubMed ID: 6407261
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
